Lunai Bioworks Inc. (LNAI), a biotechnology firm in the Healthcare sector, specializes in AI-powered therapeutics and biodefense technologies. This analysis evaluates its Shariah compliance through financial ratios, business activities, index inclusion, ESG factors, and multi-perspective views. The company fails key financial thresholds, particularly debt ratios, and is excluded from major Shariah indices due to leverage and biodefense involvement. While core therapeutic activities are permissible, purification may be required for minor non-compliant elements. Overall, LNAI is classified as non-compliant with a B quality rating, recommending monitoring for potential improvements in debt management.